author-photo

Jin-Yuan Shih

National Taiwan University

303

Papers

12435

Citations

Citation Trend

Filter By

Papers (303) Sort By

Journal Conference Others

Differences in Fatty Acid Oxidation between Nab-Paclitaxel- and Solvent-Based Paclitaxel-Treated A549 Cells Based on Metabolomics.

2021
Show All
- Source
- Cite
- Save
Citations (1)
Afatinib as First-Line Treatment in Asian Patients with EGFR Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence

2021 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (2)
Efficacy and Safety of Cone-Beam Computed Tomography-Derived Augmented Fluoroscopy Combined with Endobronchial Ultrasound in Peripheral Pulmonary Lesions.

2021 Respiration
Show All
- Source
- Cite
- Save
Citations (1)
Dual Energy CT Image Prediction on Primary Tumor of Lung Cancer for Nodal Metastasis using Deep Learning

2021 Computerized Medical Imaging and Graphics
Show All
- Source
- Cite
- Save
Citations (0)
Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non-small-cell lung cancer: a multicenter study using targeted next-generation sequencing

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Subsequent Antituberculous Treatment may not be Mandatory among Surgically Resected Culture-Negative Pulmonary Granulomas: a Retrospective Nationwide Multicenter Cohort Study

2021 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Real-world insights into patients with advanced NSCLC and MET alterations.

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
BOS172738, a highly potent and selective RET inhibitor, for the treatment of RET-altered tumors including RET-fusion+ NSCLC and RET-mutant MTC: Phase 1 study results.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Tyrosine Kinase Inhibitors Improved Survival of Critically Ill EGFR-Mutant Lung Cancer Patients Undergoing Mechanical Ventilation.

2021 Biomedicines
Show All
- Source
- Cite
- Save
Citations (0)